Skip to main content
. Author manuscript; available in PMC: 2014 Sep 19.
Published in final edited form as: Sci Transl Med. 2012 Feb 8;4(120):120ra15. doi: 10.1126/scitranslmed.3002865

Table 3.

Analysis of T cell responses performed by IFN-γ ELISpot after initial injection (bold) and after readministration. The time points for study are described in table S1. Most of the samples tested for T cell responses to the AAV capsid or the RPE65 transgene product were negative throughout the initial (18) and FO studies. A few samples tested positive in the assay (for example, CH12, FO week 6); however, these samples were negative the following week, suggesting either that the positive readings were false positives or that there was weak or transient T cell activation. Thus, there were no cell-mediated T cell responses detectable in peripheral blood, a result in agreement with the lack of local inflammation. Pos, positive (>50 SFUs per million cells plated) and at least threefold the medium-only control; Neg, negative (<50 SFUs per million cells plated) or less than threefold the medium-only control; Bkg, high background/not interpretable (medium control >100 SFUs per million cells plated).

Subject Antigen d0/FOd0 FO
week 1
Week 2/FO
week 2
FO
week 3
Week 4/FO
week 4
FO
week 5
FO
week 6
FO
week 7
FO
week 8
d90/FOd90
CH12 AAV Neg/Neg Neg Neg/Neg Neg Neg/Neg Neg Neg Neg Neg Neg*/Neg
RPE65 Neg/Neg Neg Neg/Neg Neg Neg/Neg Neg Neg Neg Neg Neg*/Neg
CH11 AAV Neg/Bkg Bkg Neg/Bkg Bkg Neg/Bkg Bkg Pos Neg Neg Neg/Neg
RPE65 Neg/Bkg Bkg Neg/Bkg Bkg Neg/Bkg Bkg Pos Neg Neg Neg/Neg
NP01 AAV Neg/Neg Neg Neg/Bkg Neg Neg/Bkg Neg Neg Bkg Neg Neg/Bkg
RPE65 Neg/Neg Neg Neg/Bkg Neg Neg/Bkg Pos Neg Bkg Neg Neg/Bkg
*

Poor viability of cells.

Positive result likely due to high background reactivity.